We identified and chose to investigate HYPOTHIOCYANITE (Chemical formula OSCN-) a very small molecule having a MW of only 74, compared to most drugs that have MWs of several thousands. OSCN- occurs in human and animal bodies to fight Pathogens as and when and where needed in the body.
Much has been written, and numerous scientific papers published, about HYPOTHIOCYANITE over the past 40 years, and they all support the message that it is highly effective in combatting all manner of pathogens. Whether they be BACTERIAL, VIRAL or FUNGAL and even the RESISTANT STRAINS of common pathogens.
See below for a selection of References that indicate the efficacy of HYPOTHIOCYANITE across all pathogens.
A full set of these selected References will be provided to those who register their interest to invest into my company.
Pathogens are causing problems everywhere and, answers to the problems.
are needed everywhere.
So, we need to go beyond the work of QURES in human health.
The future will be under a new Company having the name, of UNEEKE TECHNOLOGIES LTD.
I selected the name UNEEKE TECHNOLOGIES LTD for this company because the technology is unique and will mean a wholesale change within the medical world for thinking about treatments of infectious disease caused by different classes of Pathogens. The name unicorn, comes to mind and, it is an interesting coincidence that the Mystical Unicorn has long been associated with Good Health. Selecting a logo was easy! CLICK to see page about Unicorn and association with Good Health.
I have registered a new patent (2021) for the product and also registered the trade name OSCEAUN™ to be used as the product name.
We seek investors and funds into UNEEKE TECHNOLOGIES LTD.
UNEEKE will take on the responsibility to strengthen the knowledge and competence of and about the molecule. The first step, now that we have identified suitable raw materials, is to perform clinical work to verify the safety of the molecule and then human clinical trials against one or more conditions. Much of this work is already contracted and underway and the first of several animal and human clinical trials will happen very soon, after the Safety status is confirmed.
